CN103989953A - Traditional Chinese medicinal composition for treating infantile paralysis - Google Patents
Traditional Chinese medicinal composition for treating infantile paralysis Download PDFInfo
- Publication number
- CN103989953A CN103989953A CN201410253219.2A CN201410253219A CN103989953A CN 103989953 A CN103989953 A CN 103989953A CN 201410253219 A CN201410253219 A CN 201410253219A CN 103989953 A CN103989953 A CN 103989953A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 206010033799 Paralysis Diseases 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 33
- 241001517312 Calanthe Species 0.000 claims abstract description 5
- 208000000474 Poliomyelitis Diseases 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000207929 Scutellaria Species 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 5
- 239000000463 material Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 6
- 241000893545 Liquidambar formosana Species 0.000 abstract description 2
- 244000107975 Strychnos nux-vomica Species 0.000 abstract description 2
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000015512 Liquidambar formosana Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241001254604 Angelica pubescens Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 241000132570 Centaurea Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241001503987 Clematis vitalba Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241001074093 Echinopsis Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000218164 Menispermaceae Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241001426376 Rhaponticum uniflorum Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001113787 Strychnos Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- YTLQFZVCLXFFRK-UHFFFAOYSA-N bendazol Chemical compound N=1C2=CC=CC=C2NC=1CC1=CC=CC=C1 YTLQFZVCLXFFRK-UHFFFAOYSA-N 0.000 description 1
- 229950000900 bendazol Drugs 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine, and particularly discloses a traditional Chinese medicinal composition for treating infantile paralysis. The traditional Chinese medicinal composition is prepared by using nux vomica, liquidambar formosana hance, scutellaria baicalensis, coptis chinensis, radix angelicae pubescentis, radix stephaniae tetrandrae, rhizoma atractylodis, uniflower swisscentaury root, common calanthe herb and liquorice in a certain parts by weight. The traditional Chinese medicinal composition is scientific in compatibility, strong and stable in medical effect and quick in efficacy, does not have side effects, and ensures that infantile paralysis is difficult to relapse.
Description
Technical field
The invention belongs to lunar physics technique field, particularly a kind of Chinese medicine composition for the treatment of poliomyelitis.
Background technology
Poliomyelitis has another name called " poliomyelitis ", it is the acute infectious disease being caused by specificity neurotropic virus, damage ventricornual motor neuron, its symptom main manifestations is: heating, acroesthesia, with gastrointestinal or upper airway symptoms, limb paralysis and slowness paralysis.
The medicine of at present, treating poliomyelitis mostly both at home and abroad is the medicines such as analgesics, tranquilizer or bendazol.Last time, medicine had certain curative effect to treatment poliomyelitis, but had larger side effect and the shortcoming such as therapeutic effect is not obvious.
Summary of the invention
The present invention is in order to make up the deficiency of existing medicine, the Chinese medicine composition of the poliomyelitis that provide a kind of and have no side effect, therapeutic effect is good.
The present invention is achieved through the following technical solutions:
Treat a Chinese medicine composition for poliomyelitis, its active component is comprised of the raw material of following parts by weight: Semen Strychni 18-22 part, Fructus Liquidambaris 9-15 part, Radix Scutellariae 9-15 part, Rhizoma Coptidis 12-22 part, Radix Angelicae Pubescentis 7-12 part, Radix Stephaniae Tetrandrae 15-20 part, Rhizoma Atractylodis 7-12 part, Radix Rhapontici 7-12 part, Herba seu Radix Calanthes 5-8 part, Radix Glycyrrhizae 3-7 part.
The weight proportion of its preferred each active component is: 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is powder or pill.After various raw materials are cleaned up, co-grinding, crosses 100 mesh sieves, makes powder or pill.
The pharmaceutical characteristic of each activated feedstock is:
Semen Strychni: be Strychnos nux-vomica Linn. Loganiaceae Strychnos.Detumescence poison, removing heat from blood.Cure mainly numb limbs and tense tendons, paralysis, inappetence, mass in the abdomen, carbuncle pyogenic infections from tumour or sore, laryngopharynx swelling and pain.
Fructus Liquidambaris: be Hamamelidaceae Plants Chinese sweet gum
liquidambar formosanathe drying and ripening infructescence of Hance.Promoting blood circulation and detumescence, granulation promoting pain relieving.Be applicable to sore carbuncle, the diseases such as wound hemorrhage.
Radix Scutellariae: be a kind of plant of Labiatae Scutellaria.Heat clearing and damp drying, eliminating fire and detoxication.Cure mainly the diseases such as epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, frequent fetal movement, hypertension, carbuncle furuncle.
Rhizoma Coptidis: belong to Ranunculaceae, Coptis herbaceos perennial.Heat clearing and damp drying, eliminating fire and detoxication.For damp and hot feeling of fullness, vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, toothache, quenches one's thirst, carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated.
Radix Angelicae Pubescentis: be the dry root of samphire Angelica pubescens.Expelling wind and dampness; Dispersing cold for relieving pain.For anemofrigid-damp arthralgia; Lumbocrural pain; Few cloudy volt wind headache, headache toothache.
Radix Stephaniae Tetrandrae: be Menispermaceae woody climber.Inducing diuresis to remove edema, wind-expelling pain-stopping.Edema beriberi, dysuria, eczema sore, rheumatic arthralgia, vascular hypertension.
Rhizoma Atractylodis: be Atractylodes lancea (Thunb.) DC. Compositae, [WTBX perennial herb.Dampness, change turbid, pain relieving.Cure mainly the transporting imbalance that the spleen being blocked by dampness causes, inappetence, vomiting is unhappy, and abdominal distention is had loose bowels, arthralgia.
Radix Rhapontici: be feverfew centaurea monanthos Georgi Rhaponticum uni-florum(L.) root of DC. or Radix Echinopsis Echinps latifolius Tausch..Heat-clearing and toxic substances removing, evacuation of pus detumescence, eliminating carbuncle, stimulating milk secretion, relaxing muscles and tendons is promoted blood circulation.For acute mastitis, swell and ache, carbuncle carbuncle on the back, scrofula sore, galactostasis, arthralgia chiefly caused by damp pathogen contracture, arthralgia, toxic-heat and blood stasis, bleeding hemorrhoids.
Herba seu Radix Calanthes: be perennial herb.Eliminating stagnation, removing toxic substances, invigorates blood circulation, relaxing muscles and tendons.Cure mainly scrofula, tonsillitis, hemorrhoid, traumatic injury.
Radix Glycyrrhizae: be Glycyrrhiza uralensis Fisch. pulse family, Glycyrrhiza perennial herb.Cure mainly heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen.
In formula, Semen Strychni, Fructus Liquidambaris, Radix Scutellariae, Rhizoma Coptidis are mainly used in heat-clearing and toxic substances removing, reducing swelling and alleviating pain, and above-mentioned four medicines share and cure mainly numb limbs and tense tendons, paralysis, therefore be monarch drug.Radix Angelicae Pubescentis, Radix Stephaniae Tetrandrae, Rhizoma Atractylodis, Radix Rhapontici are mainly used in dispersing cold for relieving pain, and relaxing muscles and tendons is promoted blood circulation, and four medicines share has the effect that strengthens removing toxic substances, pain relieving, therefore be ministerial drug.Herba seu Radix Calanthes cures mainly scrofula, and traumatic injury also can be alleviated the strong of monarch drug, therefore be adjuvant drug.In the Radix Glycyrrhizae side of drawing, all medicines are to reach focus, for making medicine.
In sum, medicine of the present invention is through science compatibility, strong drug action, the efficacy of a drug rapidly, efficacy stability, there is heat-clearing and toxic substances removing, relax through promoting blood circulation, the effects such as dispersing cold for relieving pain.Treatment poliomyelitis is had to good result, and there is the feature such as be difficult for recurring, having no side effect.
The specific embodiment
Embodiment 1:
Get 18 parts of Semen Strychni, 9 parts of Fructus Liquidambaris, 9 parts of Radix Scutellariaes, 12 parts of Rhizoma Coptidis, 7 parts of Radix Angelicae Pubescentiss, 15 parts of Radixs Stephaniae Tetrandrae, 7 parts of Rhizoma Atractylodis, 7 parts of Radix Rhapontici, 5 parts of Herba seu Radix Calanthess, 3 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
Embodiment 2:
Get 22 parts of Semen Strychni, 15 parts of Fructus Liquidambaris, 15 parts of Radix Scutellariaes, 22 parts of Rhizoma Coptidis, 12 parts of Radix Angelicae Pubescentiss, 20 parts of Radixs Stephaniae Tetrandrae, 12 parts of Rhizoma Atractylodis, 12 parts of Radix Rhapontici, 8 parts of Herba seu Radix Calanthess, 7 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
Embodiment 3:
Get 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
A kind of clinical trial for the treatment of the Chinese medicine composition result of use of poliomyelitis of the present invention:
(1) object of study
(2) inventor selects polio victim 90 people, male 45 examples wherein, and female's 45 examples, the age is between 3～8 years old.Divide 3 groups, there are respectively each 15 people of men and women in every group.Group 1 is used the Chinese medicine composition of embodiment 1, and group 2 is used the Chinese medicine composition of embodiment 2, and group 3 is used the Chinese medicine composition of embodiment 3.
(2) Therapeutic Method
Oral, three times on the one, each 10～15g, one after each meal.According to conditions of patients weight, calculate treatment time, patients with mild was taken about 30 days, and severe case serve on 60 days and can fully recover.
(3) curative effect determinate standard
Cure: symptom all disappears; Main physics and chemistry detects index and is normally.
Effective: symptomatology is eliminated or cardinal symptom is eliminated; Physics and chemistry detects index normal.
Effective: cardinal symptom disappears substantially; Main physics and chemistry detects index and makes moderate progress.
Invalid: it is front unchanged with treatment that main physics and chemistry detects index.
(4) clinical effectiveness
The clinical effectiveness of group 1 is: clinical cure: 22 examples (73%), and effective 3 examples (10%), effective 2 examples (7%), invalid 3 examples (10%), total effective rate is 90%.
The clinical effectiveness of group 2 is: clinical cure: 20 examples (67%), and effective 3 examples (10%), effective 1 example (3%), invalid 6 examples (20%), total effective rate is 83%.
The clinical effectiveness of group 3 is: clinical cure: 24 examples (80%), and effective 3 examples (10%), effective 2 examples (7%), invalid 1 example (3%), total effective rate is 97%.
By above clinical trial, can be found out, embodiment 3 is optimum weight proportioning of the present invention.
Claims (3)
1. the Chinese medicine composition for the treatment of poliomyelitis, is characterized in that: the material medicine of this Chinese medicine composition and parts by weight are: Semen Strychni 18-22 part, Fructus Liquidambaris 9-15 part, Radix Scutellariae 9-15 part, Rhizoma Coptidis 12-22 part, Radix Angelicae Pubescentis 7-12 part, Radix Stephaniae Tetrandrae 15-20 part, Rhizoma Atractylodis 7-12 part, Radix Rhapontici 7-12 part, Herba seu Radix Calanthes 5-8 part, Radix Glycyrrhizae 3-7 part.
2. the Chinese medicine composition for the treatment of poliomyelitis according to claim 1, is characterized in that: the material medicine of this Chinese medicine composition and parts by weight are: 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.
3. according to the Chinese medicine composition of the treatment poliomyelitis described in claim 1 or 2 or 3, it is characterized in that: described Chinese medicine composition is powder or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410253219.2A CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410253219.2A CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103989953A true CN103989953A (en) | 2014-08-20 |
Family
ID=51304453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410253219.2A Withdrawn CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989953A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362905A (en) * | 2015-11-25 | 2016-03-02 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with pathogens diffusing into channels and collaterals |
-
2014
- 2014-06-10 CN CN201410253219.2A patent/CN103989953A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362905A (en) * | 2015-11-25 | 2016-03-02 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with pathogens diffusing into channels and collaterals |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772778B (en) | Traditional Chinese medicine composition for treating summer heat-dampness | |
| CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
| CN102145114B (en) | Novel traditional Chinese medicine for treating cold | |
| CN104740202A (en) | Medicine for treating skin itch | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN103432374A (en) | Medicine for treating pneumonia of pig | |
| CN103585401A (en) | Traditional Chinese medicine composition for treating bird flu and preparation method therefor. | |
| CN104958448A (en) | Medicine for treating puerperal infection | |
| CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
| CN104352869A (en) | Traditional Chinese medicine for treating acute upper respiratory infection and preparation method thereof | |
| CN102100817A (en) | Chinese medicinal preparation for treating infection of upper respiratory tracts | |
| CN104491825A (en) | Traditional Chinese medicine ointment for treating canker sores | |
| CN101181437B (en) | Chinese medicine composition orally taken for curing acute tonsillitis | |
| CN104189784A (en) | Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation | |
| CN103933365A (en) | Internal medicine for treating phthisis | |
| CN103301210B (en) | Traditional Chinese medicine for treating varicosity | |
| CN102389517A (en) | Traditional Chinese medicine for treating fever with swollen head | |
| CN103989953A (en) | Traditional Chinese medicinal composition for treating infantile paralysis | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN105477201A (en) | Traditional Chinese medicine preparation for treating influenza and preparation method of traditional Chinese medicine preparation for treating influenza | |
| CN105311520A (en) | Traditional Chinese medicine liniment for treating traumatic injuries | |
| CN104873862A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN102631660A (en) | Chinese medicament for treating intestinal obstruction | |
| CN103432466A (en) | Female pelvic inflammatory disease treatment traditional Chinese medicine composition and preparation method thereof | |
| CN104666806A (en) | Traditional Chinese medicine for treating epidemic meningitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 325015 Zhejiang Province, Ouhai District, No. 104 State Road, south section of the white elephant, No. 437, No. Applicant after: Guo Gensong Address before: 311404, Zhejiang, Hangzhou Province, Fuyang City cave Town, check source village, deep dock No. 31 Applicant before: Guo Gensong |
|
| COR | Change of bibliographic data | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20140820 |
|
| WW01 | Invention patent application withdrawn after publication |